Exploring the salivary proteome following intraglandular mesenchymal stromal cell therapy for radiation-induced hyposalivation in previous head and neck cancer patients: a secondary study protocol for the MESRIX-III, randomised, controlled trial
The MESRIX-III study is approved by the Danish Data Protection Agency (protocol number P-2020-1164), the National Ethics Committee (protocol number: 1802872) and the Danish Medical Agency (2018-000348-24) and is registered at the ClinicalTrials.gov database (NCT04776538). First posted on clinicaltrials.gov 03-JAN-2021.
Authors
- Simone K. Bendtsen (ORCID: https://orcid.org/0000-0002-7366-5164)
- Amanda‐Louise Fenger Carlander (ORCID: https://orcid.org/0009-0008-3840-8083)
- Kathrine Kronberg Jakobsen (ORCID: https://orcid.org/0000-0003-0336-5411)
- Charlotte Duch Lynggard
- Daniel Belstrøm (ORCID: https://orcid.org/0000-0001-7116-5388)
- Christian von Buchwald (ORCID: https://orcid.org/0000-0001-6753-8129)
- Jens Kastrup (ORCID: https://orcid.org/0000-0002-3668-5393)
- J.W. Hansen (ORCID: https://orcid.org/0000-0001-8395-5037)
- Rosa Jersie-Christensen
- Christian Grønhøj
Institutions
- Roskilde University (DK)
- University of Copenhagen (DK)
- Copenhagen University Hospital (DK)
- Rigshospitalet (DK)
Publication Details
- Journal
- Trials
- Published
- 2025-11-28
- DOI
- https://doi.org/10.1186/s13063-025-09074-4
- Primary Topic
- Salivary Gland Disorders and Functions
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Candys Foundation